NRX Pharmaceuticals Inc (NRXP) Q4 2025 Earnings Call Highlights: Strategic Advances and ...

AI Briefing

• – NRX Pharmaceuticals Inc. reports reduced operational losses
• – Anticipates key drug approvals amid financial and regulatory challenges
• – Seeks strategic partnerships to drive growth